PPARG and plasma cell myeloma: One in vitro study shows inhibition of adhesion between multiple myeloma and bone marrow stromal cells, through reduced activity of both NF-κB and C/EBPb by PPAR-γ agonists [167], reducing growth and metastasis of multiple myeloma.